3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
2
Mesothelioma, Malignant
1
Lymphatic Metastasis
1
Kidney Neoplasms
1
Head and Neck Carcinoma
1
Bone Neoplasms
1
Interventions
Indocyanine Green
7
Surgical Procedures, Operative
5
Lymph Node Excision
5
Radiotherapy, Intensity-Modulated
4
Radiotherapy
4
Radiosurgery
4
Cisplatin
4
gadofosveset trisodium
2
TP protocol
2
Sentinel Lymph Node Biopsy
2
Radiation Dose Hypofractionation
2
Magnetic Resonance Spectroscopy
2
Electroporation
2
Conversion to Open Surgery
2
Control Groups
2
Chemotherapy, Adjuvant
2
Chemoradiotherapy
2
Artificial Intelligence
2
tislelizumab
1
sarcolipin
1
lncRNA LNMAT1, human
1
gewf solution
1
fluoroazomycin arabinoside
1
X-Rays
1
Technetium-99
1
Technetium
1
Surgery, Computer-Assisted
1
Spectrum Analysis
1
Specimen Handling
1
Robotic Surgical Procedures
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Lymphatic Metastasis
×
Surgery, Computer-Assisted
×
Clear all
NCT05867095
2023-05-19
N16LND
The Netherlands Cancer Institute
Phase NA
Completed
69 enrolled